Statistics at a Glance

At a Glance

Estimated New Cases in 2018 3,450

% of All New Cancer Cases 0.2%

Estimated Deaths in 2018 1,590

% of All Cancer Deaths 0.3%

Percent Surviving
5 Years

66.9% 2008-2014
Year New Cases - SEER 9 New Cases - SEER 13 Deaths - U.S. Percent Surviving 5 Years - SEER 9
1975 0.8 - 0.9 52.2%
1976 0.8 - 0.9 56.6%
1977 0.9 - 0.9 49.4%
1978 0.9 - 0.8 49.8%
1979 0.9 - 0.5 52.5%
1980 0.8 - 0.6 48.3%
1981 0.9 - 0.5 54.3%
1982 0.8 - 0.5 54.6%
1983 0.9 - 0.5 53.4%
1984 0.9 - 0.4 48.7%
1985 0.9 - 0.5 56.4%
1986 0.8 - 0.5 66.1%
1987 0.8 - 0.4 57.6%
1988 0.8 - 0.5 62.4%
1989 0.8 - 0.5 67.9%
1990 0.8 - 0.4 66.1%
1991 1.0 - 0.5 59.4%
1992 1.0 0.9 0.5 73.2%
1993 0.9 0.9 0.5 74.2%
1994 0.9 0.9 0.5 63.2%
1995 1.0 0.9 0.5 69.3%
1996 0.8 0.9 0.5 69.8%
1997 1.0 1.0 0.4 70.3%
1998 0.9 0.9 0.5 67.6%
1999 0.9 0.8 0.4 68.9%
2000 0.9 0.8 0.4 67.0%
2001 0.9 0.9 0.5 70.5%
2002 0.9 0.9 0.4 71.9%
2003 0.8 0.9 0.4 69.9%
2004 0.9 0.9 0.4 70.0%
2005 1.0 1.0 0.5 70.9%
2006 0.9 0.9 0.4 67.9%
2007 1.0 0.9 0.4 69.1%
2008 1.0 0.9 0.4 71.1%
2009 1.1 1.0 0.4 72.9%
2010 0.9 0.9 0.4 66.7%
2011 0.9 0.9 0.4 -
2012 1.0 0.9 0.4 -
2013 0.9 0.9 0.4 -
2014 1.0 1.0 0.5 -
2015 1.0 1.0 0.4 -

Number of New Cases and Deaths per 100,000: The number of new cases of bone and joint cancer was 0.9 per 100,000 men and women per year. The number of deaths was 0.4 per 100,000 men and women per year. These rates are age-adjusted and based on 2011-2015 cases and deaths.

Lifetime Risk of Developing Cancer: Approximately 0.1 percent of men and women will be diagnosed with bone and joint cancer at some point during their lifetime, based on 2013-2015 data.

Survival Statistics

How Many People Survive 5 Years Or More after Being Diagnosed with Bone and Joint Cancer?

Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

66.9%

Percent Surviving
5 Years

66.9%

Based on data from SEER 18 2008-2014. Gray figures represent those who have died from bone and joint cancer. Green figures represent those who have survived 5 years or more.

Additional Information

Number of New Cases and Deaths

How Common Is This Cancer?

Compared to other cancers, bone and joint cancer is rare.

Rank Common Types of Cancer Estimated New
Cases 2018
Estimated
Deaths 2018
1. Breast Cancer (Female) 266,120 40,920
2. Lung and Bronchus Cancer 234,030 154,050
3. Prostate Cancer 164,690 29,430
4. Colorectal Cancer 140,250 50,630
5. Melanoma of the Skin 91,270 9,320
6. Bladder Cancer 81,190 17,240
7. Non-Hodgkin Lymphoma 74,680 19,910
8. Kidney and Renal Pelvis Cancer 65,340 14,970
9. Uterine Cancer 63,230 11,350
10. Leukemia 60,300 24,370
- - -
30. Bone and Joint Cancer 3,450 1,590

Bone and joint cancer represents 0.2% of all new cancer cases in the U.S.

0.2%

In 2018, it is estimated that there will be 3,450 new cases of bone and joint cancer and an estimated 1,590 people will die of this disease.

Who Gets This Cancer?

Osteosarcoma is most common in teenagers. Ewing Sarcoma is most common in teenagers and young adults. The number of new cases of bone and joint cancer was 0.9 per 100,000 men and women per year based on 2011-2015 cases.

Number of New Cases per 100,000 Persons by Race/Ethnicity & Sex: Bone and Joint Cancer
Males
All Races 1.1
White 1.2
Black 0.8
Asian/Pacific Islander 0.8
American Indian/Alaska Native 1.0
Hispanic 1.0
Non-Hispanic 1.1
Females
All Races 0.8
White 0.9
Black 0.6
Asian/Pacific Islander 0.5
American Indian/Alaska Native Not Shown, <16 cases
Hispanic 0.8
Non-Hispanic 0.8

SEER 18 2011-2015, Age-Adjusted

Percent of New Cases by Age Group: Bone and Joint Cancer
Age Range Percent of New Cases
<20 27.3%
20-34 15.4%
35-44 9.4%
45-54 12.1%
55-64 12.8%
65-74 11.7%
75-84 7.6%
>84 3.7%

Bone and joint cancer is most frequently diagnosed among people aged <20.

Median Age
At Diagnosis

42

SEER 18 2011-2015, All Races, Both Sexes

Who Dies From This Cancer?

The number of deaths was 0.4 per 100,000 men and women per year based on 2011-2015 deaths.

Number of Deaths per 100,000 Persons by Race/Ethnicity & Sex: Bone and Joint Cancer
Males
All Races 0.5
White 0.6
Black 0.5
Asian/Pacific Islander 0.3
American Indian/Alaska Native 0.6
Hispanic 0.5
Non-Hispanic 0.6
Females
All Races 0.3
White 0.4
Black 0.4
Asian/Pacific Islander 0.2
American Indian/Alaska Native Not Shown, <16 cases
Hispanic 0.3
Non-Hispanic 0.3

U.S. 2011-2015, Age-Adjusted

Percent of Deaths by Age Group: Bone and Joint Cancer
Age Range Percent of Deaths
<20 12.3%
20-34 13.8%
35-44 5.5%
45-54 9.3%
55-64 13.5%
65-74 16.2%
75-84 16.4%
>84 13.1%

The percent of bone and joint cancer deaths is highest among people aged 75-84.

Median Age
At Death

61

U.S. 2011-2015, All Races, Both Sexes

Trends in Rates

Changes Over Time

Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, rates for new bone and joint cancer cases have been rising on average 0.4% each year over the last 10 years. Death rates have been falling on average 0.3% each year over 2006-2015. 5-year survival trends are shown below.

More About This Cancer

Cancer and the Bone and Joint

Primary bone cancer is cancer that forms in cells of the bone. Some types of primary bone cancer are osteosarcoma, Ewing sarcoma, malignant fibrous histiocytoma, and chondrosarcoma. Secondary bone cancer is cancer that spreads to the bone from another part of the body (such as the prostate, breast, or lung). Primary bone cancer is far less common than cancer that spreads to the bones.

Bone cancer is a malignant tumor of the bone that destroys normal bone tissue. Not all bone tumors are malignant. In fact, benign (noncancerous) bone tumors are more common than malignant ones.

Common types of primary bone and joint cancer include the following:

Additional Information

More Information

Here are some resources for learning more about bone and joint cancer.

References

All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:

Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Stat Facts: Bone and Joint Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/bones.html

These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.

Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.